These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7600910)

  • 41. A method to optimize the design parameters of sustained release preparations.
    Cadorniga R; Frutos G; Martin PJ
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():385-8. PubMed ID: 1820912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Power law IVIVC: an application of fractional kinetics for drug release and absorption.
    Kytariolos J; Dokoumetzidis A; Macheras P
    Eur J Pharm Sci; 2010 Oct; 41(2):299-304. PubMed ID: 20599504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sustained release preparations: estimation of plasma concentration in the one compartment open model when release is both immediate and zero order.
    Rodda BE
    Arch Int Pharmacodyn Ther; 1971 Dec; 194(2):290-6. PubMed ID: 5126065
    [No Abstract]   [Full Text] [Related]  

  • 44. Relative bioavailability of a standard and a sustained-release quinidine tablet.
    Gibson DL; Smith GH; Koup JR; Stewart DK
    Clin Pharm; 1982; 1(4):366-8. PubMed ID: 7185532
    [No Abstract]   [Full Text] [Related]  

  • 45. The Bateman function revisited: a critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination.
    Garrett ER
    J Pharmacokinet Biopharm; 1994 Apr; 22(2):103-28. PubMed ID: 7815308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simple method for the estimation of absorption rate constant(ka) after oral administration.
    Mahmood I
    Am J Ther; 1998 Nov; 5(6):377-81. PubMed ID: 10099080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Graphic method of assessing the maximum cumulative excretion of a drug].
    Firsov AA
    Antibiotiki; 1983 Dec; 28(12):904-8. PubMed ID: 6660844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Application of the Weibull function to the study of in vivo/in vitro correlation].
    Rodriguez F; Arama E; Magbi M; Paulin T; Rouffiac R
    J Pharm Belg; 1990; 45(3):173-83. PubMed ID: 2401949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of simultaneous computer fitting to estimate the apparent absorption rate constant.
    Brouwer KR; McNamara PJ
    J Pharm Sci; 1986 May; 75(5):452-5. PubMed ID: 3735082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of assay variability on pharmacokinetic parameter estimation.
    Graves DA; Locke CS; Muir KT; Miller RP
    J Pharmacokinet Biopharm; 1989 Oct; 17(5):571-92. PubMed ID: 2614686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Convolution and validation of in vitro-in vivo correlation of water-insoluble sustained-release drug (domperidone) by first-order pharmacokinetic one-compartmental model fitting equation.
    Bose A; Wui WT
    Eur J Drug Metab Pharmacokinet; 2013 Sep; 38(3):191-200. PubMed ID: 23264125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The in vitro liberation behavior of quinidine from drug forms with prolonged release by various liberation methods].
    Appelt B; Hennig D; Wenzel U
    Pharmazie; 1986 Jan; 41(1):44-6. PubMed ID: 3960948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled release rate of a lipophilic drug (BCNU) from a refillable silicone rubber device.
    Ueno N; Refojo MF; Liu LH
    J Biomed Mater Res; 1982 Sep; 16(5):669-77. PubMed ID: 7130219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of metoclopramide on the absorption of an oral sustained-release quinidine product.
    Yuen GJ; Hansten PD; Collins J
    Clin Pharm; 1987 Sep; 6(9):722-5. PubMed ID: 3677569
    [No Abstract]   [Full Text] [Related]  

  • 55. Novel approach to the analysis of in vitro-in vivo relationships.
    Polli JE; Crison JR; Amidon GL
    J Pharm Sci; 1996 Jul; 85(7):753-60. PubMed ID: 8819002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mucus models for investigation of intestinal absorption mechanisms. 3. A mathematical simulation model of drug diffusion through enteral mucus].
    Fahr A; Guitard P; Matthes I; Nimmerfall F; Nüesch E; Sucker H
    Pharmazie; 1992 Sep; 47(9):699-704. PubMed ID: 1475317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The area function method for assessing the drug absorption rate in linear systems with zero-order input.
    Cheng H; Jusko WJ
    Pharm Res; 1989 Feb; 6(2):133-9. PubMed ID: 2762213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A nomogram to evaluate intrinsic absorption rate constants of potential oral prolonged-release candidates.
    Dyar SC; Notari RE
    Pharm Dev Technol; 1999 Aug; 4(3):305-12. PubMed ID: 10434276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of quinidine Lipettes -- a sustained release preparation.
    Eriksson JE; Hanson A; Hörlin R; Johansson BW; Ohlsson O; Otto U; Syrén G
    Acta Med Scand; 1979; 205(1-2):53-9. PubMed ID: 367087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic analysis of single- or multiple-dose plasma drug concentration data with a microcomputer using multi-fraction absorption models.
    Murata K; Tagawa K; Noda K; Samejima M
    J Pharm Sci; 1989 Feb; 78(2):154-9. PubMed ID: 2715939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.